Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease.
Standard
Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease. / Schwedhelm, Edzard; Bierend, Anneke; Maas, R; Trinks, R; Kom, G D; Tsikas, D; Böger, Rainer.
In: J THROMB HAEMOST, Vol. 8, No. 12, 12, 2010, p. 2662-2670.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Redox-generated isoprostanes are associated with residual platelet activity in aspirin-treated patients with stable coronary heart disease.
AU - Schwedhelm, Edzard
AU - Bierend, Anneke
AU - Maas, R
AU - Trinks, R
AU - Kom, G D
AU - Tsikas, D
AU - Böger, Rainer
PY - 2010
Y1 - 2010
N2 - Insufficient platelet inhibition by low-dose aspirin is associated with poor prognosis in patients with coronary heart disease (CHD). We sought to investigate the prevalence of this phenomenon in patients with stable CHD and to study whether oxidative stress plays a role in its pathogenesis.
AB - Insufficient platelet inhibition by low-dose aspirin is associated with poor prognosis in patients with coronary heart disease (CHD). We sought to investigate the prevalence of this phenomenon in patients with stable CHD and to study whether oxidative stress plays a role in its pathogenesis.
M3 - SCORING: Zeitschriftenaufsatz
VL - 8
SP - 2662
EP - 2670
JO - J THROMB HAEMOST
JF - J THROMB HAEMOST
SN - 1538-7933
IS - 12
M1 - 12
ER -